204 related articles for article (PubMed ID: 30620386)
21. Clinical significance of pathologic subtype in curatively resected ampulla of vater cancer.
Kim WS; Choi DW; Choi SH; Heo JS; You DD; Lee HG
J Surg Oncol; 2012 Mar; 105(3):266-72. PubMed ID: 21882202
[TBL] [Abstract][Full Text] [Related]
22. Ampulla of vater adenocarcinoma in a BRCA2 germline mutation carrier.
Aburjania N; Truskinovsky AM; Overman MJ; Lou E
J Gastrointest Cancer; 2014 Mar; 45(1):87-90. PubMed ID: 23417715
[No Abstract] [Full Text] [Related]
23. Clinicopathologic Features and Genetic Alterations in Mixed-Type Ampullary Carcinoma.
Kawata J; Koga Y; Noguchi S; Shimada Y; Yamada Y; Yamamoto T; Shindo K; Nakamura M; Oda Y
Mod Pathol; 2023 Aug; 36(8):100181. PubMed ID: 37004749
[TBL] [Abstract][Full Text] [Related]
24. Differentiation and prognostic markers in ampullary cancer: Role of p53, MDM2, CDX2, mucins and cytokeratins.
Perysinakis I; Minaidou E; Mantas D; Sotiropoulos GC; Leontara V; Tsipras H; Zografos GN; Margaris I; Kouraklis G
Pathol Res Pract; 2016 Nov; 212(11):1039-1047. PubMed ID: 27688085
[TBL] [Abstract][Full Text] [Related]
25. Germline Genetic Features of Young Individuals With Colorectal Cancer.
Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
[TBL] [Abstract][Full Text] [Related]
26. Prevalence of Germline Alterations on Targeted Tumor-Normal Sequencing of Esophagogastric Cancer.
Ku GY; Kemel Y; Maron SB; Chou JF; Ravichandran V; Shameer Z; Maio A; Won ES; Kelsen DP; Ilson DH; Capanu M; Strong VE; Molena D; Sihag S; Jones DR; Coit DG; Tuvy Y; Cowie K; Solit DB; Schultz N; Hechtman JF; Offit K; Joseph V; Mandelker D; Janjigian YY; Stadler ZK
JAMA Netw Open; 2021 Jul; 4(7):e2114753. PubMed ID: 34251444
[TBL] [Abstract][Full Text] [Related]
27. Statewide Retrospective Review of Familial Pancreatic Cancer in Delaware, and Frequency of Genetic Mutations in Pancreatic Cancer Kindreds.
Catts ZA; Baig MK; Milewski B; Keywan C; Guarino M; Petrelli N
Ann Surg Oncol; 2016 May; 23(5):1729-35. PubMed ID: 26727920
[TBL] [Abstract][Full Text] [Related]
28. Associations Between Cancer Predisposition Mutations and Clonal Hematopoiesis in Patients With Solid Tumors.
Franch-Expósito S; Mehine M; Ptashkin RN; Bolton KL; Bandlamudi C; Srinivasan P; Zhang L; Goodell MA; Gedvilaite E; Menghrajani K; Sánchez-Vela P; Mandelker D; Comen E; Norton L; Benayed R; Gao T; Papaemmanuil E; Taylor B; Levine R; Offit K; Stadler Z; Berger MF; Zehir A
JCO Precis Oncol; 2023 Aug; 7():e2300070. PubMed ID: 37561983
[TBL] [Abstract][Full Text] [Related]
29. Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing.
Terraf P; Pareja F; Brown DN; Ceyhan-Birsoy O; Misyura M; Rana S; O'Reilly E; Carlo MI; Aghajanian C; Liu Y; Derakhshan F; Jayakumaran G; Weigelt B; Walsh M; Stadler Z; Offit K; Ladanyi M; Robson M; Zehir A; Reis-Filho JS; Mandelker D
Ann Oncol; 2022 Apr; 33(4):426-433. PubMed ID: 35074424
[TBL] [Abstract][Full Text] [Related]
30. Identification of ampullary carcinoma mixed subtype using a panel of six antibodies and its clinical significance.
Liu F; Shen D; Ma Y; Song Q; Wang H
J Surg Oncol; 2019 Mar; 119(3):295-302. PubMed ID: 30548547
[TBL] [Abstract][Full Text] [Related]
31. Hepatocyte nuclear factor (HNF) 4α expression distinguishes ampullary cancer subtypes and prognosis after resection.
Ehehalt F; Rümmele P; Kersting S; Lang-Schwarz C; Rückert F; Hartmann A; Dietmaier W; Terracciano L; Aust DE; Jahnke B; Saeger HD; Pilarsky C; Grützmann R
Ann Surg; 2011 Aug; 254(2):302-10. PubMed ID: 21494118
[TBL] [Abstract][Full Text] [Related]
32. Expression and prognostic significance of livin, caspase-3, and ki-67 in the progression of human ampullary carcinoma.
Xue D; Zuo K; Li X; Zhang T; Chen H; Cheng Y; Chen Y
Appl Immunohistochem Mol Morphol; 2013 Dec; 21(6):525-31. PubMed ID: 23343959
[TBL] [Abstract][Full Text] [Related]
33. Pathologic T1 subclassification of ampullary carcinoma with perisphincteric or duodenal submucosal invasion: Is it T1b?
You D; Heo J; Choi S; Choi D; Jang KT
Arch Pathol Lab Med; 2014 Aug; 138(8):1072-6. PubMed ID: 25076296
[TBL] [Abstract][Full Text] [Related]
34. Tumors of the ampulla of vater: histopathologic classification and predictors of survival.
Carter JT; Grenert JP; Rubenstein L; Stewart L; Way LW
J Am Coll Surg; 2008 Aug; 207(2):210-8. PubMed ID: 18656049
[TBL] [Abstract][Full Text] [Related]
35. Concurrent MET copy number gain and KRAS mutation is a poor prognostic factor in pancreatobiliary subtype ampullary cancers.
Kwon MJ; Kim JW; Jeon JY; Nam ES; Cho SJ; Park HR; Min SK; Seo J; Min KW; Choe JY; Lee HK
Pathol Res Pract; 2017 Apr; 213(4):381-388. PubMed ID: 28214200
[TBL] [Abstract][Full Text] [Related]
36. Memorial Sloan Kettering-Integrated Mutation Profiling of Actionable Cancer Targets (MSK-IMPACT): A Hybridization Capture-Based Next-Generation Sequencing Clinical Assay for Solid Tumor Molecular Oncology.
Cheng DT; Mitchell TN; Zehir A; Shah RH; Benayed R; Syed A; Chandramohan R; Liu ZY; Won HH; Scott SN; Brannon AR; O'Reilly C; Sadowska J; Casanova J; Yannes A; Hechtman JF; Yao J; Song W; Ross DS; Oultache A; Dogan S; Borsu L; Hameed M; Nafa K; Arcila ME; Ladanyi M; Berger MF
J Mol Diagn; 2015 May; 17(3):251-64. PubMed ID: 25801821
[TBL] [Abstract][Full Text] [Related]
37. Germline TP53 Mutations in Patients With Early-Onset Colorectal Cancer in the Colon Cancer Family Registry.
Yurgelun MB; Masciari S; Joshi VA; Mercado RC; Lindor NM; Gallinger S; Hopper JL; Jenkins MA; Buchanan DD; Newcomb PA; Potter JD; Haile RW; Kucherlapati R; Syngal S;
JAMA Oncol; 2015 May; 1(2):214-21. PubMed ID: 26086041
[TBL] [Abstract][Full Text] [Related]
38. High-grade neuroendocrine carcinoma of the ampulla of vater: a clinicopathologic and immunohistochemical analysis of 14 cases.
Nassar H; Albores-Saavedra J; Klimstra DS
Am J Surg Pathol; 2005 May; 29(5):588-94. PubMed ID: 15832081
[TBL] [Abstract][Full Text] [Related]
39. Cancers of the papilla of vater: mutator phenotype is associated with good prognosis.
Achille A; Biasi MO; Zamboni G; Bogina G; Iacono C; Talamini G; Capella G; Scarpa A
Clin Cancer Res; 1997 Oct; 3(10):1841-7. PubMed ID: 9815572
[TBL] [Abstract][Full Text] [Related]
40. Comprehensive analysis of germline drivers in endometrial cancer.
Gordhandas S; Rios-Doria E; Cadoo KA; Catchings A; Maio A; Kemel Y; Sheehan M; Ranganathan M; Green D; Aryamvally A; Arnold AG; Salo-Mullen E; Manning-Geist B; Sia T; Selenica P; Da Cruz Paula A; Vanderbilt C; Misyura M; Leitao MM; Mueller JJ; Makker V; Rubinstein M; Friedman CF; Zhou Q; Iasonos A; Latham A; Carlo MI; Murciano-Goroff YR; Will M; Walsh MF; Issa Bhaloo S; Ellenson LH; Ceyhan-Birsoy O; Berger MF; Robson ME; Abu-Rustum N; Aghajanian C; Offit K; Stadler Z; Weigelt B; Mandelker DL; Liu YL
J Natl Cancer Inst; 2023 May; 115(5):560-569. PubMed ID: 36744932
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
